Map Chem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.50 M
as on 17-11-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 17-11-2024
- Satisfied Charges ₹ 3.85 Cr
as on 17-11-2024
- Revenue 8.06%
(FY 2023)
- Profit 14.95%
(FY 2023)
- Ebitda 96.34%
(FY 2023)
- Net Worth 24.46%
(FY 2023)
- Total Assets 103.06%
(FY 2023)
About Map Chem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹3.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankit Sethia and Ashish Sethia serve as directors at the Company.
- CIN/LLPIN
U51496MH2004PTC148271
- Company No.
148271
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Map Chem Private Limited offer?
Map Chem Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Antifungal Injection, Tablet & Syrup, Common Disease Medicines, Skin Lightening Drugs, Nutraceuticals & Dietary Supplements, Protein Supplement, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Map Chem?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ankit Sethia | Director | 01-Aug-2012 | Current |
Ashish Sethia | Director | 27-Aug-2004 | Current |
Financial Performance of Map Chem.
Map Chem Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.06% increase. The company also saw a substantial improvement in profitability, with a 14.95% increase in profit. The company's net worth Soared by an impressive increase of 24.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Map Chem?
In 2023, Map Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of Baroda Creation Date: 17 Jan 2015 | ₹1.00 Cr | Open |
Development Credit Bank Limited Creation Date: 29 Jul 2013 | ₹6.00 M | Satisfied |
The Cosmos Co-Operative Bank Ltd. Creation Date: 28 Mar 2005 | ₹3.25 Cr | Satisfied |
How Many Employees Work at Map Chem?
Unlock and access historical data on people associated with Map Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Map Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Map Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.